Literature DB >> 24070262

The distinguishing cellular features of pulmonary artery smooth muscle cells from chronic thromboembolic pulmonary hypertension patients.

Lei Wang1, Hui-Li Gan, Yan Liu, Song Gu, Jing Li, Li-Juan Guo, Jie Liu, Ying Wang, Yue-Xiu Wang, Zhi-Fei Zhang, Jun Wang, Chen Wang.   

Abstract

In chronic thromboembolic pulmonary hypertension (CTEPH), central thrombi are the most likely disease initiators, and progressive pulmonary vascular remodeling, which is characterized by marked proliferation of pulmonary artery smooth muscle cells (PASMCs), may also contribute to the long-term progression of CTEPH. This study was designed to investigate the cellular characteristics of PASMCs isolated from the organized thrombotic tissues of CTEPH. In the present study, analysis of PASMCs isolated from five CTEPH patients and three control subjects showed that cells from CTEPH patients had certain characteristics that distinguished them from control cells, including inferior or no cell-cell contact inhibition growth, increased sensitivity to hypoxia-induced proliferation, resistance to serum starvation-induced apoptosis, and mitochondrial metabolism disorder. These differences in the PASMCs in endarterectomized tissue of CTEPH patients may prove useful in understanding the pathobiology of CTEPH.

Entities:  

Mesh:

Year:  2013        PMID: 24070262     DOI: 10.3109/01902148.2013.822947

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  2 in total

1.  3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.

Authors:  Jie Liu; Wang Wang; Lei Wang; Xian-Mei Qi; Yu-Hui Sha; Ting Yang
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

2.  Clinical importance of the distribution of pulmonary artery embolism in acute pulmonary embolism.

Authors:  Yunqiang Nie; Li Sun; Wei Long; Xin Lv; Cuiyun Li; Hui Wang; Xing Li; Ping Han; Miao Guo
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.